Genus plc

As of December 31, 2025, Genus plc carries a market capitalization of 172.34B, placing it among publicly traded companies globally. Its enterprise value stands at 194.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Genus plc's next confirmed earnings release is scheduled for February 25, 2027.

As of December 31, 2025, Genus plc has 66.41M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Genus plc maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Genus plc's stock has declined approximately 13.85% over the past 52 weeks. The 50-day moving average sits at 2,225.16, while the 200-day moving average is 2,430.37.

As of December 31, 2025, Genus plc holds 4.34B in cash and equivalents against 26.07B in total debt, resulting in a net debt position of 19.02B. Total book value stands at 50.40B, with working capital of 16.91B providing operational flexibility.